Fresenius "overweight" - AktienCheck PDF Print

New York (aktiencheck.de AG) - Thomas Jones und James D. Gordon, Analysten von JP Morgan Securities, bewerten die Aktie von Fresenius (ISIN DE0005785604 ...

read more

 
Share |
Copyright © 2024 Global Dialysis. All Rights Reserved.